How Ancillary Services Are Increasing Healthcare Practice Valuations

Practice valuations in healthcare M&A are rarely set by patient volume and physician productivity alone. Buyers have become more sophisticated about what drives durable EBITDA, and ancillary services now sit near the center of that conversation. For a practice preparing for a transaction, or for an owner thinking several years ahead, how ancillaries are built, operated, and positioned often has more influence on enterprise value than any single clinical metric.

The underlying reason is straightforward. A practice that captures revenue beyond the professional fee, whether through in-office diagnostics, an ambulatory surgery center, pathology, optical, or other integrated services, looks fundamentally different on an underwriting model. It has more ways to grow, more stability across a cycle, and a larger runway for a buyer to expand after close. None of those advantages show up if ancillaries are treated as an afterthought.

What Counts as an Ancillary Service

Ancillary services are the clinical and operational offerings that sit alongside a practice’s core professional work and generate revenue beyond the office visit. Depending on specialty, they can include:

• Imaging, including X-ray, ultrasound, MRI, and in-office diagnostics
• Laboratory and pathology services
• Physical therapy and rehabilitation
• Ambulatory surgery center (ASC) ownership or joint venture participation
• In-office dispensing or specialty pharmacy
• Durable medical equipment
• Optical retail, aesthetic product sales, and other cash-pay lines

The common thread is that each captures revenue inside the practice or its affiliated entities that would otherwise leave the system through an outside referral. Done well, ancillaries build a more comprehensive care model for patients and a more durable financial model for the business.

Why Ancillaries Lift Valuation

The most obvious reason is revenue diversification. A practice whose income depends almost entirely on evaluation and management visits is fully exposed to changes in commercial rates, Medicare fee schedules, and patient volume in a single service line. A practice with established ancillary revenue is not. Buyers underwrite that diversification as reduced risk, and reduced risk is part of what supports a higher multiple.

The second reason is margin profile. Many ancillary services operate at materially higher margins than office visits. A procedure performed in an ASC, imaging conducted on in-house equipment, or pathology processed internally generates professional and technical fees together, and the incremental cost of each additional unit is often modest once the infrastructure is in place. Because transactions in this market are typically valued on EBITDA, incremental margin flows through to valuation more directly than incremental revenue does.

The third reason is growth runway. When a buyer evaluates a platform-quality practice, they are paying in part for what the business can become, not only what it is today. A practice that has already stood up ancillaries has demonstrated it can execute that kind of build, which makes future expansion more credible. A practice with meaningful ancillary opportunity still ahead of it can also command strong pricing, though the balance between upfront value and rollover participation may shift accordingly.

Patient Experience as a Financial Input

Ancillaries also change the patient experience in ways that eventually show up in the financials. Consolidating services inside a single practice or network reduces the number of visits a patient has to coordinate, shortens the path from diagnosis to treatment, and improves communication across the team. Patients who receive more of their care in one place tend to stay longer, refer more often, and rate the practice higher, all of which feed back into volume and retention.

This isn’t a soft argument. Retention and referral patterns are among the most important inputs into a practice’s long-term growth curve, and buyers pay attention to them during diligence. A practice with ancillaries that are actually used by its patient base, rather than simply listed on a website, tends to show healthier retention metrics and a more predictable forward pipeline.

Operational Integration, Not Just Co-Location

The clinical and operational benefits of ancillaries depend on real integration rather than physical proximity. The practices that extract the most value from in-house diagnostics, therapy, or procedural capacity tend to have a few things in common. Imaging results are read and acted on quickly because the workflow is built for it. Lab results feed into treatment decisions without a delay. Therapy plans are aligned with the physician’s clinical plan because the teams talk. Scheduling is coordinated across service lines so a patient can complete several steps in one visit.

When ancillaries are run this way, they improve throughput and outcomes at the same time. When they aren’t, they can become an operational drag: equipment that isn’t fully utilized, staff that doesn’t have enough work, or services that patients don’t know to ask for. The difference usually comes down to management discipline rather than the specific mix of services offered.

What Buyers Look For in Ancillary Build-Out

Private equity sponsors and strategic buyers evaluating a practice tend to look at ancillaries through a fairly consistent lens. The questions that come up repeatedly include:

• How established and stable is the existing ancillary revenue
• What portion of ancillary opportunity has been captured versus what remains available
• How is the infrastructure set up to support replication across additional sites
• How clean is the regulatory structure, including Stark and Anti-Kickback compliance
• How is physician ownership in ASCs, labs, or other ancillary entities structured, and how will it be treated in a transaction

A practice that can answer these questions clearly, with supporting documentation, is usually in a stronger negotiating position. A practice that has grown ancillaries opportunistically without attention to structure can still complete a transaction, but the process tends to be more complicated, and some portion of value can be left on the table in diligence.

Regulatory Discipline Is Part of the Valuation Story

Ancillary services sit directly in the path of the federal and state regulatory frameworks that govern physician self-referral and financial relationships. The Stark Law, the Anti-Kickback Statute, and in some states corporate practice of medicine restrictions all affect how ancillaries can be structured and operated. None of these frameworks prevent practices from building ancillaries. They do, however, set clear rules about how ownership, referrals, compensation, and facility arrangements must be handled.

In a transaction, buyers conduct detailed diligence on these issues. Weaknesses in structure, documentation, or historical compliance show up quickly and can translate directly into reduced valuation, indemnity requirements, or in some cases a failed process. Owners who plan to transact in the foreseeable future are well served by addressing compliance proactively rather than treating it as a closing-table exercise. Competent healthcare counsel and experienced advisors should be involved well before a process begins.

How Practice Owners Should Think About Building Ancillaries

For a practice owner weighing whether and how to invest in ancillary services, the decision is strategic rather than purely financial. A few questions are worth pressing on before committing capital:

• What ancillary lines match the clinical profile and patient volume of the practice
• What is the realistic utilization, not the theoretical capacity, for each service
• What does the investment cost look like, and over what period does it pay back
• What staffing, management, and systems are required to run the service well
• How does the ancillary strategy position the practice for a transaction at the time the owners expect to pursue one

Timing matters as well. Ancillaries that are built well in advance of a sale usually contribute more to valuation than those assembled in the months before a process begins. Buyers can distinguish between established operations and recent additions, and they underwrite accordingly.

About The Bloom Organization

The Bloom Organization is a healthcare-focused, sell-side M&A advisory firm with more than thirty years of experience representing physician groups, healthcare operators, and middle-market healthcare businesses. Securities transactions are conducted through Bloom Securities, LLC, a member of FINRA and SIPC.

Our advisory work related to ancillary services and practice value includes:

• Representing physician groups with meaningful ancillary and ASC operations in sale processes
• Advising owners on how existing ancillary revenue is likely to be valued by different buyer types
• Guiding practices on ancillary and ASC strategy in the years leading up to a transaction
• Structuring transactions that address physician ownership in ancillary entities, rollover equity, and post-close economics
• Helping sponsors and platforms evaluate the quality and growth potential of ancillary operations within acquisition targets

If you’re a practice owner thinking about how ancillaries would be valued in a transaction, or considering how to build them in a way that supports your long-term plans, we’d welcome the conversation.